South Africa: Insights From The UK Private Healthcare Inquiry – A Taste Of Things To Come?

Last Updated: 16 April 2014
Article by Jocelyn Katz, Wade Graaff and Schalk Van Rensburg

Most Read Contributor in South Africa, September 2018

Launching a market inquiry into a certain, seemingly problematic sector of the South African economy is not a new modus operandi for the South African Competition Commission (the "SA Commission"). In the past the SA Commission has relied upon general powers found in the Competition Act, No. 89 of 1998 (as amended) (the "Competition Act") to conduct a market inquiry into the retail banking sector (the "Banking Inquiry") and the supermarket sector (the "Supermarket Inquiry").

As there were no express provisions authorising and regulating market inquiries at that time, participation in the Banking Inquiry was effectively voluntary in nature. Consequently, the outcome of the Banking Inquiry was dependant on the assistance of those members of the industry wishing or willing to submit relevant information to the SA Commission. Surprisingly, despite these voluntary submissions, the Banking Inquiry did not yield any staggering anti-competitive findings or result in any significant restructuring in the industry.

Similarly, in the Supermarket Inquiry, the SA Commission decided not to take any action after concluding an investigation that lasted for over three and a half years and considered the exclusive long-term lease agreements in place between six major supermarkets and property developers, owners and managers.

There's no guarantee that the healthcare market inquiry (the "SA healthcare inquiry") initiated by the SA Commission will result in the same conclusions as the Banking and Supermarket Inquiries given that the SA Commission now has a wide range of statutory powers conferred upon it in terms of the Competition Amendment Act, No. 1 of 2009 that it did not previously have. Chapter 4A of the Competition Act, which became effective on 1 April 2013, now makes explicit provision for market inquiries and enables the SA Commission to force parties to participate in the inquiry through various means, including the issue of summons to appear and/or provide relevant documents to the SA Commission. It empowers the SA Commission to initiate complaints or to enter into consent agreements with the relevant respondents. These provisions give some indication that the current and future market inquiries will not all reach the same outcomes as the Banking and Supermarket Inquiries as the SA Commission now has the necessary statutory weapons to effect change in markets where an inquiry has produced anti-competitive findings.

Chapter 4A of the Competition Act mirrors the market investigation provisions contained in the United Kingdom's (the "UK") Enterprise Act of 2002. Moreover, on 4 April 2012 the UK Competition Commission (the "UK Commission") received a referral from the Office of Fair Trading (the "OFT") to investigate the private healthcare market in the UK. This investigation, which has a statutory deadline of 3 April 2014, is in its final stages and the final report thereon is scheduled to be published during March 2014. As such, it would be prudent to take note of the provisional findings and the proposed remedies published to date by the UK Commission as these provide useful insight into the possible outcomes for the Healthcare Inquiry.

After a two year long inquiry and investigation into the UK's private healthcare system, the UK Commission has published its provisional findings and proposed remedies after it provisionally found adverse effects on competition and resulting customer detriment. More particularly, such remedies are being proposed after it identified high barriers to entry and expansion for full service hospitals and weak competitive constraints in certain local markets as two structural features of the private healthcare industry that have an adverse effect on competition. These features, in turn, lead to higher prices for self-paying patients and to higher prices for insured patients where a private hospital operator has market power over private medical insurers in negotiations.

In addition to the structural features of the sector, the UK Commission identified various problematic conduct features as well. In particular, the UK Commission found that the existence of incentive schemes by private hospital operators to encourage patient referrals to their hospitals has an adverse effect on competition. This conduct feature distorts the referral decisions by doctors or specialists to a certain hospital and distorts a patient's choice of diagnosis and treatment options in certain circumstances. Furthermore, the UK Commission identified the lack of publically available information on the performance of private hospitals and the performance and fee information of consultants as a feature that has an adverse effect on competition. As a result of this, private hospital patients are prevented from exercising effective choice in selecting the private hospitals at which to be treated and patients are prevented from exercising effective choice in selecting which consultants by whom to be diagnosed and treated. This, in turn, reduces competition between private hospitals, and consultants, on the basis of quality and price.

To address these findings, the UK Commission has proposed the following package of remedies:

  • the divesture of nine hospitals, two hospitals owned by the Hospital Corporation of America and seven hospital owned by BMI Healthcare, a subsidiary Netcare;
  • a review by the OFT or the newly formed Competition and Markets Authority (which will be taking over many of the functions and responsibilities of the UK Commission and the OFT in April 2014) of arrangements under which private hospital operators enter into agreements to operate private patient units in the UK's National Health Service hospitals and prohibition of such arrangements if they fail a competition test;
  • a prohibition of, or restrictions on, certain clinician incentive schemes that encourage patient referrals to particular facilities or for particular treatments or tests;
  • requiring the collection and publication of information on the performance of private hospitals and individual consultants; and
  • requiring that private hospital operators include as a condition in the granting of practising privileges an obligation on consultants to provide fee information to patients using standard letter templates and that private hospital operators ensure that consultants comply with this obligation.

The process followed by the UK Commission throughout its two year investigation placed certain burdens and obligations upon the parties involved in the inquiry. Parties to the inquiry were subject to, inter alia, the answering of questionnaires, site visits by the UK Commission, hearings conducted by the UK Commission and the submission of various responses to the UK Commission including to its provisional findings and proposed remedies.

The proposed remedies, particularly the potential divestiture of hospitals, are quite serious in nature and should serve as an indication of potential things to come for South African firms which find themselves involved in the SA healthcare inquiry. The SA healthcare inquiry commenced on 6 January 2014 and is scheduled for completion on 30 November 2015. The SA Commission's preliminary findings (which will be further tested during the inquiry) have identified, in its recently published terms of reference, that the South African healthcare sector is characterised by many challenges related to the uneven distribution of coverage and access to funding, poor infrastructure and human resources constraints. In respect of private healthcare, the SA Commission has stated that various concerns have been raised regarding the functioning of the market as a result of the fact that healthcare expenditure and prices across key segments are rising above headline inflation. These increases, states the SA Commission, are framing the inquiry into the sector.

In respect of concentration levels, the SA Commission has identified that there has been consolidation in respect of hospital groups (3 groups share 87.8% of the total number of beds in the national private hospital market), administrators (3 entities represent 78.2% of the total number of beneficiaries of medical schemes on a national basis) and medical schemes (3 schemes cover 55.5% of all beneficiaries of medical schemes).

If the UK healthcare inquiry is anything to go by, and taking into account the new powers available the SA Commission, the South African inquiry (which will be led by former Chief Justice Sandile Ngcobo (Chairperson), Professor Sharon Fonn, Dr Ntuthuko Bhengu, Dr Lungiswa Nkonki and Mr Cornelis van Gent) could result in extensive recommendations being made to the Minister of Economic Development and, if any potential contraventions of the Competition Act are uncovered, further prosecutions being pursued. Although the SA Commission's administrative process is yet to be published, firms can expect that the inquiry will be extensive and thorough and will require internal attention on a daily basis.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions